Reaction
Myopericarditis reporting signals
As of the last recalculation, Myopericarditis appears in 704 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is MESALAMINE (PRR 75.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mesalamine | 120 | 75.9 | 76.1 |
| Colchicine | 34 | 40.1 | 40.1 |
| Fondaparinux Sodium | 8 | 29.5 | 29.6 |
| Posaconazole Delayed-Release | 10 | 27.3 | 27.3 |
| Tretinoin | 7 | 25.7 | 25.8 |
| Anakinra | 13 | 23.6 | 23.6 |
| Baricitinib | 7 | 21.7 | 21.7 |
| Posaconazole | 11 | 20.3 | 20.3 |
| Thiotepa | 6 | 18.7 | 18.7 |
| Mesna Injection | 5 | 18.0 | 18.0 |
| Mesna | 5 | 17.7 | 17.7 |
| Imatinib | 10 | 17.0 | 17.0 |
| Fluorouracil Cream, 0.5% | 40 | 16.4 | 16.4 |
| Fluorouracil | 40 | 16.1 | 16.2 |
| Azacitidine For | 9 | 14.8 | 14.8 |
| Azacitidine | 13 | 13.2 | 13.2 |
| Dasatinib | 10 | 8.1 | 8.1 |